Suppr超能文献

左主干冠状动脉疾病的药物洗脱与灌注治疗的首例人体技术。

The First-in-Man Technique of Drug Eluting and Perfusion Therapy for Left Main Coronary Artery Disease.

作者信息

Warisawa Takayuki, Kawai Yoshiki, Matsumoto Takuya, Sato Shingo, Takeyama Makoto, Nakamura Yuta, Katsushika Susumu, Katsura Aritomo, Sato Takahiro, Matsushita Masashiro, Ando Jiro

机构信息

Department of Cardiology, NTT Medical Center Tokyo, Tokyo, Japan.

Department of Medical Engineering, NTT Medical Center Tokyo, Tokyo, Japan.

出版信息

Catheter Cardiovasc Interv. 2025 Aug;106(2):978-987. doi: 10.1002/ccd.31621. Epub 2025 May 29.

Abstract

BACKGROUND

Treating ostial left circumflex artery (LCx) lesions in percutaneous coronary intervention (PCI) for left main disease (LMD) remains a challenge. Despite recent recommendations for the use of drug-coated balloon (DCB) in this lesion, there are concerns about crossover-stenting from the left main trunk (LMT) to the left anterior descending artery (LAD). Specifically, isolated DCB treatment for the ostial LCx lesion may induce carina shift, while conventional kissing balloon technique (C-KBT) with a standard balloon and a DCB may prolong LMT occlusion, leading to hemodynamic instability.

OBJECTIVES

This study aimed to evaluate the safety and feasibility of a novel double-effect KBT (W-KBT) using a perfusion balloon (PB) for the LMT-LAD and a DCB for the LMT-LCx, allowing prolonged inflation while maintaining coronary perfusion.

METHODS

This single-center prospective study enrolled consecutive patients with de-novo LMD and ostial LCx lesions, requiring crossover-stenting from the LMT to the LAD followed by proximal optimization technique and C-KBT. After confirming optimal PCI, W-KBT was performed.

RESULTS

Among 12 enrolled patients (mean age 73.8 ± 7.2, 91.7% men), procedural success, defined as device delivery and W-KBT time ≥ 30 s, was achieved in all cases via the transradial approach. W-KBT inflation-time was consistently 60 s; ST changes occurred in 50% (no ST-elevation); mean ST-change time was 41.2 ± 7.1 s; mean delta-blood pressure was -13.7 ± 11.4 mmHg; mean delta-heart rate was -3.4 ± 5.9 bpm; and no inotropes or mechanical cardiac support were needed.

CONCLUSION

Within the limited sample size of this pilot study, the safety and feasibility of the first-in-man W-KBT were suggested.

SUMMARY

This pilot study evaluated the safety and feasibility of a novel double-effect kissing balloon technique (W-KBT) in percutaneous coronary intervention for left main coronary artery disease, realized by the combined use of a perfusion balloon and a drug-coated balloon. Among 12 patients, device delivery was successful via a transradial approach using a 7 Fr guiding catheter. The W-KBT was maintained for 60 s without hemodynamic instability, providing adequate drug application to the ostial left circumflex artery lesion. Furthermore, no ST-elevation or periprocedural myocardial infarction was observed, highlighting the safety and feasibility of this technique.

摘要

背景

在经皮冠状动脉介入治疗(PCI)中,处理左主干病变(LMD)时,左回旋支动脉(LCx)开口处病变的治疗仍然是一项挑战。尽管最近有关于在该病变中使用药物涂层球囊(DCB)的建议,但人们担心从左主干(LMT)到左前降支动脉(LAD)的交叉支架置入。具体而言,单纯使用DCB治疗LCx开口处病变可能会导致隆突移位,而使用标准球囊和DCB的传统亲吻球囊技术(C-KBT)可能会延长LMT闭塞时间,导致血流动力学不稳定。

目的

本研究旨在评估一种新型双效亲吻球囊技术(W-KBT)的安全性和可行性,该技术使用灌注球囊(PB)用于LMT-LAD,使用DCB用于LMT-LCx,可在维持冠状动脉灌注的同时延长球囊充盈时间。

方法

本单中心前瞻性研究纳入了连续的新发LMD和LCx开口处病变患者,这些患者需要从LMT到LAD进行交叉支架置入,随后采用近端优化技术和C-KBT。在确认PCI最佳效果后,进行W-KBT。

结果

在12例纳入的患者中(平均年龄73.8±7.2岁,男性占91.7%),所有病例均通过桡动脉途径实现了手术成功,手术成功定义为器械输送和W-KBT时间≥30秒。W-KBT充盈时间始终为60秒;50%的患者出现ST段变化(无ST段抬高);平均ST段变化时间为41.2±7.1秒;平均血压变化为-13.7±11.4mmHg;平均心率变化为-3.4±5.9次/分;无需使用正性肌力药物或机械心脏支持。

结论

在本初步研究的有限样本量范围内,首次在人体应用的W-KBT的安全性和可行性得到了提示。

总结

本初步研究评估了一种新型双效亲吻球囊技术(W-KBT)在经皮冠状动脉介入治疗左主干冠状动脉疾病中的安全性和可行性,该技术通过联合使用灌注球囊和药物涂层球囊实现。在12例患者中,使用7F引导导管经桡动脉途径成功进行了器械输送。W-KBT维持60秒,无血流动力学不稳定,为LCx开口处病变提供了足够的药物应用。此外,未观察到ST段抬高或围手术期心肌梗死,突出了该技术的安全性和可行性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验